JPWO2021102322A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021102322A5
JPWO2021102322A5 JP2022529831A JP2022529831A JPWO2021102322A5 JP WO2021102322 A5 JPWO2021102322 A5 JP WO2021102322A5 JP 2022529831 A JP2022529831 A JP 2022529831A JP 2022529831 A JP2022529831 A JP 2022529831A JP WO2021102322 A5 JPWO2021102322 A5 JP WO2021102322A5
Authority
JP
Japan
Prior art keywords
alkyl
independently selected
optionally substituted
cyclic peptide
obz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022529831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502745A5 (https=
JP2023502745A (ja
JP7836759B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/061596 external-priority patent/WO2021102322A1/en
Publication of JP2023502745A publication Critical patent/JP2023502745A/ja
Publication of JPWO2021102322A5 publication Critical patent/JPWO2021102322A5/ja
Publication of JP2023502745A5 publication Critical patent/JP2023502745A5/ja
Application granted granted Critical
Publication of JP7836759B2 publication Critical patent/JP7836759B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022529831A 2019-11-21 2020-11-20 細胞透過性環状ペプチドおよびその使用 Active JP7836759B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962938864P 2019-11-21 2019-11-21
US62/938,864 2019-11-21
US202063047178P 2020-07-01 2020-07-01
US63/047,178 2020-07-01
PCT/US2020/061596 WO2021102322A1 (en) 2019-11-21 2020-11-20 Cell-permeable cyclic peptides and uses thereof

Publications (4)

Publication Number Publication Date
JP2023502745A JP2023502745A (ja) 2023-01-25
JPWO2021102322A5 true JPWO2021102322A5 (https=) 2023-12-01
JP2023502745A5 JP2023502745A5 (https=) 2023-12-01
JP7836759B2 JP7836759B2 (ja) 2026-03-27

Family

ID=75981727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529831A Active JP7836759B2 (ja) 2019-11-21 2020-11-20 細胞透過性環状ペプチドおよびその使用

Country Status (7)

Country Link
US (1) US20220411471A1 (https=)
EP (1) EP4061397A4 (https=)
JP (1) JP7836759B2 (https=)
CN (1) CN115297883A (https=)
CA (1) CA3159182A1 (https=)
IL (1) IL293239A (https=)
WO (1) WO2021102322A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313092A (zh) * 2021-05-26 2023-04-01 美商非自然產物公司 細胞可穿透環狀肽及其用途
TW202417032A (zh) 2022-08-23 2024-05-01 日商富士軟片股份有限公司 環肽或其鹽及mdmx抑制劑
TW202417465A (zh) 2022-08-23 2024-05-01 日商富士軟片股份有限公司 環肽或其鹽及mdmx抑制劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166003A1 (en) * 1999-06-14 2003-09-04 Cochran Andrea G. Structured peptide scaffold for displaying turn libraries on phage
AU2008360223B2 (en) * 2008-08-08 2014-06-19 Polyphor Ag Template-fixed peptidomimetics
JP2014001189A (ja) * 2012-06-20 2014-01-09 Osaka Prefecture Univ 抗腫瘍ペプチド化合物
EP3243522A1 (en) * 2016-05-10 2017-11-15 Université Pierre et Marie Curie (Paris 6) Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
CN110114075B (zh) * 2016-11-09 2024-01-12 俄亥俄州国家创新基金会 含有二硫化物的细胞穿透肽及其制备和使用方法
US11446388B2 (en) * 2016-12-23 2022-09-20 Heidelberg Pharma Research Gmbh Amanitin antibody conjugates
CN110452289A (zh) * 2019-07-10 2019-11-15 江苏申琅生物科技有限公司 一类新型mdm2环肽抑制剂的设计及其制备方法

Similar Documents

Publication Publication Date Title
Morales et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass
EP1332137B1 (en) Treatment of gastrointestinal stromal tumors
JP2018525425A5 (https=)
CN101903045B (zh) 用于治疗白内障的药物组合物
JP5875585B2 (ja) 緑内障および高眼圧症の処置のためのアデノシンa1アゴニスト
JPWO2021102322A5 (https=)
KR101206319B1 (ko) 티아졸 유도체를 포함하는 수성 조성물
JPWO1996032101A1 (ja) 癌転移抑制剤
CN101784285B (zh) 用于与低氧或局部缺血有关的眼科疾病的组合物
JPWO2003024445A1 (ja) 抗血栓薬とピラゾロン誘導体との組み合わせ薬剤
JPWO2020150113A5 (https=)
JPWO2021032643A5 (https=)
Hirata et al. Changes in hemodynamics in patients who underwent extended mediastinal lymphadenectomy through median sternotomy for primary lung cancer
JP2005314348A (ja) 顔面神経麻痺治療剤
JPWO2019213153A5 (https=)
JPWO2022150911A5 (https=)
KR20260020956A (ko) 간 질환을 가진 환자의 내장 혈관 확장증의 치료에 사용하기 위한 라니피브라노르
RU2023127302A (ru) Производные индолина, как ингибиторы ddr
JPH0665089A (ja) 血管拡張剤
JPWO2019243822A5 (https=)
JPWO2022271861A5 (https=)
KR980002018A (ko) 치화된 벤젠디카복실산 디구아니드, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
JPWO2023018891A5 (https=)
JP2000239188A (ja) 育毛剤
CA2229074A1 (en) Nitric oxide synthase (nos) inhibitors